Ultraviolet radiation and cutaneous carcinogenesis

Current Problems in Dermatology

Volumn 35, Issue , 2007, Pages 14-27

  Molho Pessach, Vered ^a   Lotem, Michal ^a,b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL TRANSFORMATION; DNA DAMAGE; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; SKIN TUMOR; ULTRAVIOLET RADIATION;

CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HUMANS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 34547541145     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000106407     Document Type: Article

References (66)

1. Diepgen TL, Mahler V: The epidemiology of skin cancer. Br J Dermatol 2002;146(suppl 61):1-6.
2. Nguyen TH, Ho DQ: Nonmelanoma skin cancer. Curr Treat Options Oncol 2002;3:193-203.
3. Kripkr ML, Ananthaswamy HA: Carcinogenesis: ultraviolet radiation; in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S (eds): Fitzpatrick's Dermatology in General Medicine, ed 6. New York, McGraw-Hill, 2003, pp 371-377.
4. Madronich S, McKenzie RL, Bjorn LO, Caldwell MM: Changes in biologically active ultraviolet radiation reaching the Earth's surface. J Photochem Photobiol B 1998;46:5-19.
5. Norval M, Cullen AP, de Gruijl FR, Longstreth J, Takizawa Y, Lucas RM, Noonan FP, van der Leun JC: The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci 2007;6:232-251.
6. Walker SL, Hawk JLM, Young AR: Acute and chronic effects of ultraviolet radiation on the skin; in Freedberg IM, Eisen AZ, Wolfi K, Austen KF, Goldsmith LA, Katz S (eds): Fitzpatrick's Dermatology in General Medicine, ed 6. New York, McGraw-Hill, 2003, pp 1275-1282.
7. De Gruijl FR: Skin cancer and solar radiation. Eur J Cancer 1999;35:2003-2009.
8. Fears TR, Scotto J, Schneiderman MA: Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United States. Am J Epidemiol 1977;105: 420-427.
9. Almahroos M, Kurban AK: Ultraviolet carcinogenesis in nonmelanoma skin cancer. I. Incidence rates in relation to geographic locations and in migrant populations. Skinmed 2004;3:29-35.
10. Almahroos M, Kurban AK: Ultraviolet carcinogenesis in nonmelanoma skin cancer. II. Review and update on epidemiologic correlations. Skinmed 2004;3:132-139.
11. Madan V, Hoban P, Strange RC, Fryer AA, Lear JT: Genetics and risk factors for basal cell carcinoma. Br J Dermatol 2006;154(suppl 1):5-7.
12. Sterenborg HJCM, van der Leun JC: Action spectra for tumorigenesis by ultraviolet radiation; in Passichier WF, Bosnjakovic BFM (eds): Human Exposure to Ultraviolet Radiation: Risks and Regulations. Amsterdam, Elsevier, 1987, p 173.
13. Sterenborg HJCM, van der Leun JC: Tumorigenesis by a long wavelength UV-A source. Photochem Photobiol 1990;51:325-330.
14. Lacour JP: Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002;146(suppl 61):17-19.
15. Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP, et al: Ultraviolet and ionizing radiation enhance the growth of BCC and trichoblastomas in patched heterozygous knockout mice. Nat Med 1999;5:1285-1291.
16. Enk CD, Shahar I, Amariglio N, Rechavi G, Kaminski N, Hochberg M: Gene expression profiling of in vivo UVB-irradiated human epidermis. Photodermatol Photoimmunol Photomed 2004;20: 129-137.
17. Cadet J, Sage E, Douki T: Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005;571:3-17.
18. Jiang N, Taylor JS: In vivo evidence that UV-induced C→T mutations at dipyrimidine sites could result from the replicative bypass of cis-syn cyclobutane (timers or their deamination products. Biochemistry 1993)32:472-481.
19. Kappes UP, Luo D, Potter M, Schulmeister K, Runger TM: Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J Invest Dermatol 2006;126:667-675.
20. Mouret S, Baudouin C, Chaveron M, Favier A, Cadet J, Douki T: Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci USA 2006;103:13567-13568.
21. Besaratinia A, Synold TW, Chen HH, Chang C, Xi B, Riggs AD, Pfeifer GP: DNA lesions induced by UV Al and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci USA 2005;102:10058-10063.
22. Nishigori C: Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci 2006;5:208-214.
23. Halliday GM: Inflammation, gene mutation in response to UVR-induced and photoimmunosuppression oxidative damage contributes to photocarcinogenesis. Mutat Res 2005;571:107-120.
24. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, et al: UV-induced skin damage. Toxicology 2003;189:21-39.
25. Hanneman KK, Cooper KD, Baron ED: Ultraviolet immunosuppression mechanisms and consequences. Dermatol Clin 2006;24:19-25.
26. Narbutt J, Lesiak A, Skibinska M, Wozniacka A, van Loveren H, Sysa-Jedrzejowska A, Lewy-Trenda I, Omulecka A, Norval M: Suppression of contact hypersensitivity after repeated exposures of humans to low doses of solar simulated radiation. Photochem Photobiol Sci 2005;4:517-522.
27. McLoone P, Norval M: Adaptation to the UV-induced suppression of phagocytic activity in murine peritoneal macrophages following chronic exposure to solar simulated radiation. Photochem Photobiol Sci 2005;4:792-797.
28. Swindells K, Rhodes LE: Influence of oral antioxidants on ultraviolet radiation-induced skin damage in humans. Photodermatol Photoimmunol Photomed 2004;20:297-304.
29. Brash DE, Ziegler A, Jonason AS, et al: Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996;1:136-142.
30. Melnikova VO, Ananthaswamy HN: Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005;571:91-106.
31. Nelson WG, Kastan MB: DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response. Mol Cell Biol 1994;14:1815-1823.
32. Amundson SA, Patterson A, Do KT, et al: A nucleotide excision repair master-switch: p53 regulated coordinate induction of global genomic repair genes. Cancer Biol Ther 2002;1:145-149.
33. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-299.
34. Nakano K, Voudsen KH: PUMA, a novel proapoptotic gene is induced by p53. Mol Cells 2001;7:683-694.
35. Kuhn C, Hurwitz SA, Kumar MG, Cotton J, Spandau DF: Activation of the insulin-like growth factor alpha receptor promotes survival of humna keratinocytes following ultraviolet B irridation. Int J Cancer 1999;80:431-438.
36. Peus D, Vasa RA, Meves A, et al: UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival. Photochem Photobiol 2000;72:135-140.
37. Nelson MA, Einspahr JG, Alberts DS, Balfour CA, Wymer JA, Welch KL, et al: Analysis of p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 1994;85:23-29.
38. Campbell C, Quinn AG, RoYS, Agus B, Rees JL: P53 mutations are common and early events that precede tumor invasion in squamous cell neoplasis of the skin. J Invest Dermatol 1993;100:746-748.
39. Stem RS, Lander EJ: Risk of squamous cell carcinoma in patients treated with oral methoxsalen (psoralen) and UV-A radiation: a meta-analysis, Arch Dermatol 1994;134:1582.
40. Mudgil Ay Segal N, Andriani F, Wang Y, Fusenig NE, Garlick JA: Ultraviolet B irradiation induces expansion of intraepithelial tumor cells in a tissue model of early cancer progression. J Invest Dermatol 2003;121:191-197.
41. Gruijl FR, van der Leun JC: Development of skin tumors in hairless mice after discontinuation of ultraviolet irradiation. Cancer Res 1991;51:979-984.
42. Nishigori C: UV induced damage in carcinogenesis and its repair. J Dermatol Sci 2000;23(suppl 1):S41-S44.
43. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Anathaswamy HN: Ras gene and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991;4:196-202.
44. Brown VL, Harwood CA, Crook T, Cronin JG, Kelsell DP, Proby CM: P16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol 2004;122:1284-1292.
45. Pfister H: Chapter 8: human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31:52-56.
46. Boukamp P: Non-melanoma skin cancer: what drives tumor development and progression? Carcinogenesis 2005;26:1657-1667.
47. Stockfleth E, Ulrich C, Meyer T, Arndt R, Christophers E: Skin diseases following organ transplantation - risk factors and new therapeutic approaches. Transplant Proc 2001;33:1848-1853.
48. Stockfleth E, Ulrich C, Meyer T, Christophers E: Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002;160:251-258.
49. Bouwes-Bavinck JN: Epidemiological aspects of immunosuppression: role of exposure to sunlight and HPV on the development of skin cancer. Hum Exp Toxicol 1994;14:98.
50. Stern RS, Liebman EJ, Vakeva L: Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst 1998;90:1278-1284.
51. Cooke MS, Evans MD, Burd RM, Patel K, Barnard A, Lunec J, et al: Induction and excretion of ultraviolet-induced 8-oxo-2′-deoxyguanosine and thymine dimers in vivo: implications for PUVA. J Invest Dermatol 2001;116:281-285.
52. Gray SE, Kay EW, Leader M, Mabruk MJ: Enhanced detection of microsatellite instability and mismatch repair gene expression in cutaneous squamous cell carcinomas. Mol Diagn Ther 2006;10:327-334.
53. Johnson RL, Rothman AL, Xie J, Goodrich Ly Bare JW, Bonifass JM, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996:272:1668.
54. Ingham PW: Transducing hedgehog: the story so far. EMBO J 1998;17:3505.
55. Miller AJ, Mihm MC: Melanoma. N Engl J Med 2006;355:51-65.
56. Pavey S, Gabrielli B: Alpha-melanocyte stimulating hormone potentiates p16/CDKN2A expression in human skin after ultraviolet irradiation. Cancer Res 2002;62:875-880.
57. Beaumont KA, Newton RA, Smit DJ, Leonard JH, Stow JL, Sturm RA: Altered cell surface expression of human MClR variant receptor alieis associated with red hair and skin cancer risk. Hum MoI Genet 2005;14:2145-2154.
58. Ley RD: Animal models of ultraviolet radiation (UVR)-induced cutaneous melanoma. Front Biosci 2002;7:d1531-d1534.
59. Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru y Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B; French Hereditary Melanoma Study Group: Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma. J Med Gene 2006;43:39-47.
60. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG: Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol 2000;136:1118-1122.
61. Davis KJ, Cokkinides VE, Weinstock MA, O'Connell MC, Wingo PA: Summer sunburn and sun exposure among US youths ages 11 to 18: national prevalence and associated factors. Pediatrics 2002;110:27-35.
62. Wright TI, Spencer JM, Franklin PF: Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 2006;54:933-946.
63. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, De Luca LM: Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;21:1271-1279.
64. Chen K, Craig JC, Shumack S: Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 2005;152:518-523.
65. Bouwes Bavinck JN, Tieben LM, van der Woude FJ, et al: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind placebo controlled study. J Clin Oncol 1995;13:1933-1938.
66. de Sevaux RGL, Smit JV, de Jong EMGJ, et al: Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomised trial comparing two doses of acitretin. J Am Acad Dermatol 2003;49:407-412.